Litigation Details for iCeutica Pty Ltd. v. Apotex, Inc. (D. Del. 2017)
✉ Email this page to a colleague
iCeutica Pty Ltd. v. Apotex, Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-10-31 |
| Court | District Court, D. Delaware | Date Terminated | 2018-06-08 |
| Cause | 35:271 Patent Infringement | Assigned To | Vacant Judgeship |
| Jury Demand | Plaintiff | Referred To | Christopher J. Burke |
| Patents | 8,679,544; 8,999,387; 9,017,721; 9,173,854; 9,180,095; 9,180,096; 9,186,328 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in iCeutica Pty Ltd. v. Apotex, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for iCeutica Pty Ltd. v. Apotex, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-10-31 | 1 | United States Patent Nos. 8,679,544 (“the ’544 patent”), 8,999,387 (“the ’387 patent”), 9,017,721 (“…(“the ’721 patent”), 9,173,854 (“the ’854 patent”), 9,180,095 (“the ’095 patent”), 9,180,096 (“the ’096…’096 patent”), and 9,186,328 (“the ’328 patent”) under the Patent Laws of the United States, 35 U.S.C…copy of the ’544 patent is attached hereto as Exhibit A. 27. The ’387 patent, entitled “Formulation…copy of the ’387 patent is attached hereto as Exhibit B. 28. The ’721 patent, entitled “Formulation | External link to document | |
| 2018-06-08 | 39 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,679,544 ;8,999,387 ;9,017,721… 2017 8 June 2018 1:17-cv-01553 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
